J Biol Chem, Vol. 274, Issue 32, 22275-22282, August 6, 1999
The aroC Gene of Aspergillus nidulans
Codes for a Monofunctional, Allosterically Regulated Chorismate
Mutase*
Sven
Krappmann,
Kerstin
Helmstaedt,
Thomas
Gerstberger,
Sabine
Eckert,
Bernd
Hoffmann,
Michael
Hoppert,
Georg
Schnappauf, and
Gerhard
H.
Braus
From the Institute of Microbiology & Genetics,
Georg-August-University, Grisebachstrasse 8, D-37077 Göttingen, Germany
 |
ABSTRACT |
The cDNA and the chromosomal locus of the
aroC gene of Aspergillus nidulans were cloned
and is the first representative of a filamentous fungal gene encoding
chorismate mutase (EC 5.4.99.5), the enzyme at the first branch point
of aromatic amino acid biosynthesis. The aroC gene
complements the Saccharomyces cerevisiae aro7
as well as
the A. nidulans aroC mutation. The gene consists of three exons interrupted by two short intron sequences. The expressed mRNA
is 0.96 kilobases in length and aroC expression is not
regulated on the transcriptional level under amino acid starvation
conditions. aroC encodes a monofunctional polypeptide of
268 amino acids. Purification of this 30-kDa enzyme allowed
determination of its kinetic parameters (kcat = 82 s
1, nH = 1.56, [S]0.5 = 2.3 mM), varying pH dependence of
catalytic activity in different regulatory states, and an acidic pI
value of 4.7. Tryptophan acts as heterotropic activator and tyrosine as
negative acting, heterotropic feedback-inhibitor with a
Ki of 2.8 µM. Immunological data,
homology modeling, as well as electron microscopy studies, indicate
that this chorismate mutase has a dimeric structure like the S. cerevisiae enzyme. Site-directed mutagenesis of a crucial residue
in loop220s (Asp233) revealed differences concerning the
intramolecular signal transduction for allosteric regulation of
enzymatic activity.
 |
INTRODUCTION |
Chorismic acid is the last common compound in the biosynthesis of
aromatic amino acids. The metabolic branch leading to
L-tryptophan is initiated by its conversion to anthranilate
catalyzed by the enzyme anthranilate synthase (EC 4.1.3.27), whereas
the catalytic reaction to prephenate finally leads to
L-phenylalanine and L-tyrosine (1, 2). The
latter reaction is the only known Claisen rearrangement in primary
metabolism of living organisms and is catalyzed by a unique enzyme, the
chorismate mutase (EC 5.4.99.5) (3). Chorismate mutases are found in
archaea, bacteria, fungi, and plants (4). Based on primary sequence
information and determination of the crystal structure of three natural
enzymes, chorismate mutases are classified into two groups: the
chorismate mutase of Bacillus subtilis represents the AroH
class and is characterized by its trimeric pseudo
/
-barrel
structure (5, 6). In contrast, polypeptides of the AroQ class are
all-helix bundle proteins and are often part of a bifunctional enzyme
containing a chorismate mutase domain (7). According to Hilvert and
co-workers (8), eukaryotic chorismate mutases, which additionally
contain regulatory domains, also fall into the latter class despite of
the rare primary amino acid sequence similarity with their prokaryotic
counterparts. The enzymatic properties of some eukaryotic chorismate
mutases have been studied in detail, but only a limited number of the corresponding genes have been cloned yet (4).
The chorismate mutase of the bakers' yeast Saccharomyces
cerevisiae is the most prominent member of the AroQ class and has been characterized in extensive studies (9-11). Its allosteric modulation by tyrosine and tryptophan serves as a model in
understanding the regulatory properties of a branch point enzyme.
Determination of different crystal structures has given insight into
the structural basis for the regulatory processes controlling the flux
of chorismate into one of the two branches in the biosynthesis of
aromatic amino acids (see Ref. 12, and references therein). In
addition, molecular dynamics studies have given hints to understand the
mechanism of the enzymatic conversion performed by this enzyme (13).
The homodimeric yeast enzyme consists of 2 × 12 helices with the
catalytically active domain built up by three helices of each subunit.
The loop preceding one of these helices has turned out to be crucial
for transmitting the signal of T to R state transition. Conversion of
one residue in this loop (T226I) results in a constitutively activated
enzyme that is unresponsive to its inhibitor tyrosine (14).
To date, no gene coding for a chorismate mutase of a filamentous fungus
has been characterized. Here we present the characterization of the
chorismate mutase-encoding gene aroC of Aspergillus
nidulans. This filamentous fungus has become a model organism
concerning metabolism as well as differentiation in recent decades (15, 16). The aroC gene product was overexpressed in yeast using recombinant DNA technology and then purified for kinetic assays and
regulatory analysis. The quarternary structure was determined by
computer modeling and compared with the yeast enzyme. Additionally, site-directed mutagenesis was applied to investigate the role of a
putatively crucial residue (Asp233) in allosteric
transition as this amino acid residue corresponds to residue
Thr226 in the yeast chorismate mutase. We found that the
newly characterized chorismate mutase shares structural similarities
with its yeast homologue, but that the molecular basis of the mechanism
for T-R transition is not conserved.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Chorismic acid as barium salt was purchased from
Sigma. Ethylamino-Sepharose was prepared following the protocol for
activation of Sepharose CL-4B (17) and by coupling of the ligand
ethylamine-HCl to the activated matrix. Protein solutions were
concentrated by using stirred cells (volumes of 180 and 10 ml) with
PM-10 ultrafiltration membranes from Millipore (Eschborn, Germany). The
Mini 2D SDS-polyacrylamide gel electrophoresis system and the Bradford
protein assay solution for determination of protein concentrations
originated from Bio-Rad. Vent polymerase (BIOLABS, Schwalbach, Germany)
was used for polymerase chain reactions. All other chemicals were
supplied by FLUKA (Neu-Ulm, Germany) or Sigma-Aldrich Chemie GmbH
(Steinheim, Germany).
Strains, Media, cDNA Library, Plasmids, Growth
Conditions--
The S. cerevisiae strain RH2185
(MATa, suc2-
9, ura3-52, leu2-3, leu2-112, his4-519,
aro7::LEU2, GAL2) (10) with the genetic background of
the laboratory strain X2180-1A (MATa, gal2, SUC2, mal, CUP1)
was used as recipient for cloning of an aroC cDNA out of
an inducible expression library. The expression library was constructed
after mRNA isolation from A. nidulans strain FGSC A234
(yA2, pabaA1, veA1) using the SuperscriptTM
cDNA Synthesis Kit from Life Technologies, Inc. (Gaithersburg, MD).
cDNAs were ligated as SalI/NotI fragments in
the shuttle vector pRS316-GAL1 (18) and propagated in
Escherichia coli. Yeast transformation was carried out as
described in Ref. 19. Transformation of A. nidulans was
carried out according to Punt and van den Hondel (20). For
overexpression, a derivative of plasmid p426MET25 (21) was used in the
S. cerevisiae strain RH2192 (MATa, pra1-1,
prb1-1, prc1-1, cps1-3, ura3
5, leu2-3, 112, his
, aro7::LEU2) which is a
derivative of the protease-deficient strain c13-ABYS-86 (22). The
A. nidulans strain G1100 (aroC1248, riboA1, adG14,
yA2) was described earlier (23) and was obtained from J. Clutterbuck, Glasgow, United Kingdom. MV minimal medium for the
cultivation of yeast was described earlier (24) and minimal medium for
the cultivation of A. nidulans strains was prepared
according to Käfer (25).
Site-directed Mutagenesis--
A polymerase chain reaction-based
method was used for site-directed mutagenesis of aroC
(26). The polymerase chain reaction-generated fragments were sequenced
(27) to confirm the presence of the mutations and to rule out
second-site mutations.
RNA Preparation and Analysis--
Total RNA was prepared from
vegetatively growing A. nidulans cultures using the
TRIzolTM reagent from Life Technologies, Inc. following the
supplier's instructions. Transcript levels were analyzed by Northern
hybridization (28) using a Bio-Imaging Analyzer from Fuji Photo Film
Co. Ltd. (Tokyo, Japan). Transcript length was determined using the
0.16-1.77-kb1 RNA ladder
from Life Technologies, Inc.
Overexpression and Purification of A. nidulans Chorismate
Mutase--
Plasmid-carrying yeast strains were grown at 30 °C in
10-liter rotatory fermentors under aeration. Cells were harvested in mid-log phase at an OD546 nm of 4-6, washed twice with 50 mM potassium phosphate buffer, pH 7.6, and stored in 1 ml
of buffer/g wet cells at
20 °C in the presence of protease
inhibitors (0.1 mM phenylmethylsulfonyl fluoride (PMSF),
0.2 mM EDTA, and 1 mM
DL-dithiothreitol). For purification, 80-110 g of cells
were thawed and run three times through a French Pressure Cell (18,000 p.s.i.). Cell debris was sedimented by centrifugation at 30,000 × g for 20 min.
The chorismate mutase was purified according to the protocol of
Schmidheini et al. (14) with the following modifications: in
all steps 10 mM potassium phosphate buffer, pH 7.6, was
used as solvent, ammonium sulfate precipitation was carried out at 47%
saturation, phenylmethylsulfonyl fluoride was added to the equilibration buffer for the ethylamino-Sepharose column, dialysis was
used to desalt protein extracts, and a second run on a Mono Q column at
pH 5.8 in 10 mM potassium phosphate buffer was performed. Chorismate mutase was detected by SDS-polyacrylamide gel
electrophoresis (29) and enzymatic activity assays. Measurements of
protein concentrations were performed using the Bradford assay
(30).
Enzyme Assays--
Chorismate mutase activity was measured as
described previously (9) with some modifications. The enzymatic
conversion is stopped after 1 min by addition of HCl and the product of
the enzymatic reaction, prephenate, is converted to phenylpyruvate through a chemical reaction. Enzymatic activity is measured
spectrophotometrically, determining the concentration of
phenylpyruvate. Since absorbance of phenylpyruvate is
temperature-dependent due to a keto-enol equilibrium, the
assay was standardized by keeping the enzymatic reactions at 30 °C
and equilibrating the spectrophotometer cell to the same temperature.
Reaction volumes of 250 µl containing 100 mM potassium
phosphate, pH 7.6, 2 mM EDTA, 20 mM
dithiothreitol, optionally 50 µM tyrosine or 5 µM tryptophan, chorismate mutase enzyme, and chorismate
in a range from 0.25 to 13 mM were used. The reaction was
started by adding the mixture of all ingredients to the prewarmed
chorismate solution. The reaction was stopped by adding 250 µl of 1 M HCl. After an incubation time of 10 min, 4 ml of 1 M NaOH were added and extinction at 320 nm was measured against H2O. To exclude absorbance caused by the
uncatalyzed rearrangement of chorismate, blanks of increasing
chorismate concentrations without enzyme were prepared and absorbance
was measured. These blank absorbances were subtracted from optical
densities measured for enzyme activities. A calibration curve was drawn
using different known phenylpyruvate concentrations that were treated
the same way as the enzyme reactions. The molecular extinction
coefficient at 30 °C was determined as 13095 M
1 cm
1. For determination of
the pH optima, a universal buffer solution with a pH range of 2.5-12
containing 30 mM citric acid, 30 mM KH2PO4, 30 mM
H3BO4, 30 mM diethylbarbituric acid
and different amounts of NaOH was used.
The collected data were transformed to international units (µmol
min
1) per mg of enzyme. The maximum velocity
Vmax, the Hill-coefficient nH, and the substrate concentration at
half-maximal velocity [S]0.5 or Km
were determined using a computer program which applied the Quasi-Newton
method (Davidon-Fletcher-Powell algorithm) to fit optimal curves to the
data (31). To draw substrate saturation curves, the data were fitted
either to the Michaelis-Menten equation (v = Vmax [S] (Km + [S])-1) or to the Hill equation (v = Vmax [S]n ([S]n + S')
1), where S'(1/n) = S0.5. Eadie-Hofstee plots (v
[S]
1 versus v) were drawn to
decide which equation a set of kinetic data had to be applied. Enzyme
kinetics without cooperativity result in a linear curve, whereas even
small degrees of cooperativity result in concave curvatures of the
kinetic data (32). Hill plots (log(v
(Vmax
v)
1)
versus log [S]) were used to calculate Hill coefficients.
The resulting Vmax values were transformed to
catalytic constants (kcat = Vmax Mr
E0
1 (60 s)
1;
substrate turnover per active site). The inhibitor constant Ki for tyrosine was determined according to Dixon by plotting v
1 versus inhibitor
concentration (33).
Determination of the Native Molecular Weight--
The native
molecular weight of the chorismate mutase was estimated by gel
filtration on a Superdex 200 prep grade column using 50 mM
potassium phosphate, 150 mM NaCl, pH 7.6, as elution
buffer. The void volume of the column was determined with blue dextran and a calibration plot was defined using a gel filtration
chromatography standard from Bio-Rad containing thyroglobulin, bovine
-globulin, chicken ovalbumin, equine myoglobin, and vitamin B-12. In
addition, the molecular weight was determined independently by
sedimentation equilibrium at 50,000 rpm (16 °C) and calculation of
the sedimentation coefficient and the molecular mass. Three different
concentrations of the enzyme in 20 mM potassium phosphate
buffer, pH 7.6, were used and all ultracentrifugal analyses were
performed on a Beckmann XLA. To confirm the results obtained by gel
filtration and analytical ultracentrifugation, the molecular weight was
estimated by native polyacrylamide gel electrophoresis using a gradient
from 4 to 20% polyacrylamide (34).
Determination of the Isoelectric Point--
The isoelectric
point of the chorismate mutase enzyme was determined using the Bio-Rad
Rotofor system according to the supplier's instructions. A pH gradient
in 18 ml of 10 mM potassium phosphate buffer, pH 7.6, was
set up by a Bio-LyteTM ampholyte ranging from pH 3.5 to 9.5 in a concentration of 0.5%. 100 µg of purified protein were applied
to the focusing chamber and after 4 h the run was completed. The
content of the focusing chamber was fractionated and the pH of each
fraction was measured. Before detection of chorismate mutase, NaCl was
applied to 1 M final concentration and fractions were
dialyzed against 10 mM potassium phosphate, pH 7.6. Chorismate mutase was detected by enzyme assays as well as by
SDS-polyacrylamide gel electrophoresis.
Electron Microscopy--
Negative staining of protein samples
was performed as described in Ref. 35 with 4% uranyl acetate solution.
Electron microscopic images were taken at a EM 301 transmission
electron microscope (Philips, Eindhoven, Netherlands) at an
acceleration potential of 80 kV. Magnification was calibrated using a
cross-grid replica.
Western Blot Analysis--
Immunological detection of chorismate
mutase proteins was performed using a polyclonal rabbit antibody raised
against purified yeast chorismate mutase (10) and a second antibody
with horseradish peroxidase activity. Detection was carried out using
the ECL method (36).
Sequence Alignment and Homology Modeling Studies--
All
sequence analyses were performed using the LASERGENE Biocomputing
software from DNAstar (Madison, WC). Alignments were created based on
the Lipman-Pearson method (37). For homology modeling, the deduced
primary structure of the A. nidulans chorismate mutase was
aligned to the crystallographic data of yeast chorismate mutases as
described in the Brookhaven protein data base (12) by ProModII (38) and
refined by the SWISS-MODEL service (39, 40). Using the MOLMOL software
(41), a three-dimensional structure model could be established by
calculation of secondary structures.
 |
RESULTS |
Isolation of the aroC Gene from A. nidulans--
The
aroC gene from A. nidulans was cloned by
functional complementation of a S. cerevisiae aro7
mutant
strain (10). Yeast strains with a deleted ARO7 gene do not
contain any chorismate mutase activity and therefore were unable to
grow on minimal medium lacking tyrosine or phenylalanine. Yeast strain
RH2185 (aro7::LEU2, ura3-52) was
transformed with A. nidulans cDNA expressed from the
GAL1 promoter (18) and transformants were selected by growth on medium lacking tyrosine and phenylalanine containing 2% galactose as the sole carbon source. A total of 80 colonies were obtained, from
which plasmids were isolated that could complement the Phe/Tyr auxotrophy of the recipient aro7
yeast strain. One of the
plasmids (pME1498) was further analyzed by DNA sequencing of the
SalI/NotI fragment containing the cDNA
insert. The cDNA without poly(A) tail is 927 bp in length and
includes an open reading frame of 804 bp with 267 codons which
correspond to a polypeptide with a calculated Mr
of 30,660. Alignment of the deduced amino acid sequence shows strong
homology to the chorismate mutase sequence of S. cerevisiae
with 44% identity (Fig. 1). The homology
goes up to 67% when conservative changes are taken into account.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 1.
The chorismate mutase of A. nidulans shows homology to the S. cerevisiae
enzyme. The alignment shows a comparison of the deduced
amino acid sequence of A. nidulans chorismate mutase
(AnCM) with that of S. cerevisiae
(ScCM). Identical residues are indicated by vertical
bars, conservative replacements by colons, and neutral
changes by periods.
|
|
The genomic region encoding the cDNA insert of pME1498 was isolated
and analyzed. Southern blot analysis of this region, using the cDNA
of pME1498 as a probe, revealed that the corresponding gene exists as
single copy in the A. nidulans genome (data not shown). A
sublibrary of A. nidulans genomic HindIII
fragments of 4-6 kb in size was screened by colony hybridization with
the aroC cDNA probe and resulted in a 5-kb fragment
which was subjected to DNA sequence analyses (Fig.
2A). The genomic fragment
contains the same open reading frame as the cDNA, flanked by a
1.2-kb 5'-region and a 2.7-kb 3'-region, and is interrupted by two
short intron sequences. Intron I is located 70 bp downstream of the
translational start site and is 113 bp in length, while intron II is
located 77 bp upstream of the stop codon UAG and 49 bp in size. Both
show the conserved 5' splicing, internal, and 3' splicing sequences described for A. nidulans introns (42). Sequence analysis
for upstream regulatory sequences in the promoter region of
aroC indicated a putative STUA-binding site 560 nucleotides
upstream of the translational start codon. This sequence element
(5'-ACGCGAAA-3') matches the described consensus for STUA response
elements (StRE, 5'-(A/T)CGCG(T/A)N(A/C)-3') (43). In addition, a
sequence element (5'-GAGTCA-3') was identified 571 bp upstream of the
translational start codon that matches the described consensus sequence
for a Gcn4p-binding site (GCRE, 5'-TGACTC-3') in reverse orientation
(44).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 2.
Structure of the aroC gene
and expression under amino acid starvation conditions.
A, schematic drawing of a genomic
HindIII/AatII DNA fragment containing the
aroC gene. The GenBank accession number for this sequence is
AF133241. Solid boxes indicate the open reading frame
interrupted by two introns. A putative STUA-binding site is indicated
by the solid triangle and a Gcn4p response element in
reverse orientation by the open triangle. A,
AatII; B, BstEII; EI,
EcoRI; EV, EcoRV; H,
HindIII; P, PvuII; Sa,
SalI; St, StuI; X,
XbaI. B, Northern analysis of total RNA prepared
from A. nidulans strain FGSC A234 (yA2,
pabaA1, veA1) different time points after
shifting to medium containing 3-amino-1,2,4-triazole (3AT).
Each lane was loaded with 20 µg of total RNA and probed successively
with probes specific for aroC, trpC, and
gpdA. Ethidium bromide-stained total RNA is included as
control.
|
|
A. nidulans mutant strains auxotrophic for phenylalanine and
tyrosine have been isolated before (23). One complementation class of
these mutants was named aroC and mapped to linkage group I
(45). The described phenotype of aroC mutant strains
prompted us to test whether the gene isolated was able to complement
the auxotrophy of aroC mutants. For this purpose, the
genomic HindIII fragment was transformed into strain G1100
(aroC1248, riboA1, adG14, yA2) for ectopic integration and
transformants were selected on medium lacking phenylalanine and
tyrosine. For 90% of the isolated transformants a complementation of
the Phe/Tyr auxotrophy was observed, indicating that we had isolated
the aroC gene of A. nidulans, which codes for the
chorismate mutase enzyme.
aroC Expression Is Not Regulated Transcriptionally upon Amino Acid
Starvation--
By Northern blot analysis using an RNA size standard
the transcript length of aroC was determined to be
approximately 0.96 kb (not shown). As the aroC gene product
is an enzyme of the aromatic amino acid biosynthetic pathway and
because of the existence of a putative GCRE in its promoter region we
were interested in whether aroC expression is affected by
amino acid starvation conditions. For that purpose, A. nidulans strain FGSC A234 (yA2, pabaA1,
veA1) was cultivated in liquid minimal medium for 20 h
and mycelia were transferred to fresh medium containing
3-amino-1,2,4-triazole (3AT). This reagent acts as false
feedback-inhibitor on the histidine biosynthesis and therefore mimics
amino acid starvation by depletion of the histidine pool within the
fungus (46). After different time points mycelium was harvested and
total RNA was prepared. Following Northern blot the aroC
transcript levels were determined by probing with the cDNA
fragment. Additionally, the levels of the gpdA (47) and the
trpC (48) transcripts were detected with specific probes
serving as internal controls (Fig. 2B). gpdA, which encodes
an enzyme of glycolysis (glyceraldehyde-3-phosphate dehydrogenase, EC
1.2.1.12), is known to be unregulated in its transcription upon
3-amino-1,2,4-triazole addition. In contrast, trpC, which
codes for a trifunctional enzyme of tryptophan biosynthesis, has been
shown to be transcriptionally regulated by amino acid starvation
conditions. Quantification of signal strength reveals constant
expression of aroC after shifting to amino acid starvation conditions. Expression of gpdA shows the identical pattern,
whereas trpC transcription is increased by a factor of 15, 8 h after the onset of the environmental stimulus. Therefore we
conclude that transcription of the aroC gene is not affected
by a regulatory network that acts upon the environmental signal amino
acid starvation.
Chorismate Mutase of A. nidulans Is Regulated by Tyrosine and
Tryptophan--
The enzyme was purified by overexpression in S. cerevisiae strain RH2192 (aro7::LEU2,
ura3-52) from a high-copy plasmid carrying the A. nidulans
aroC cDNA fragment driven by the MET25 yeast
promoter. The protein was enriched 64-fold and purified to homogeneity
to determine the properties of the aroC gene product.
Kinetic stop assays with the unliganded enzyme were performed to reveal
the catalytic properties of the A. nidulans chorismate mutase (Fig. 3A, Table
I). In the absence of effectors the
enzyme shows positive cooperativity toward its substrate chorismate
leading to a sigmoidal substrate saturation curve. A
[S]0.5 value of 2.3 mM and a Hill coefficient
nH of 1.56 were determined and the maximal turnover rate kcat was calculated to be 82 s
1 per active site. By isoelectric focusing, the pI of
the protein was determined to be at an acidic pH of 4.7 (data not
shown). The solvent pH also has an influence on the catalytic activity of the enzyme (Fig. 3C). Without any effector bound,
chorismate mutase activity reaches its maximum at a pH of 5.9.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 3.
Characteristics of A. nidulans
chorismate mutase. A, substrate saturation plot
of enzyme assays. The enzyme was assayed with 5 µM
tryptophan ( ), without effector ( ), or in the presence of 50 µM tyrosine ( ). The data were fitted to functions
describing cooperative or Michaelis-Menten-type saturation. Specific
activities are mean values of five independent measurements with a
standard deviation not exceeding 20%. B, Dixon plot of
enzyme assays in the presence of tyrosine at different concentrations.
Specific activities were measured in the presence of 2 mM
( ), 3 mM ( ), and 4 mM ( ) substrate and
plotted reciprocally versus tyrosine concentrations. The
point of intersection determines the inhibitory constant
Ki for tyrosine. C, pH optima for
chorismate mutase activities under different effector conditions at 1 mM chorismate concentration. The optima are given on the
right side. D, determination of native molecular weight by
gel filtration. Calibration of a Superdex 200 column was performed as
described under "Experimental Procedures." Using a void volume of
47.19 ml as determined by blue dextran and a total column volume of 120 ml, the Kd of the native chorismate mutase ( ) was
calculated to be 0.67. This value corresponds to a polypeptide with an
apparent molecular mass of 62,187 Da.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Kinetic parameters of chorismate mutase enzyme from A. nidulans
Values for kcat, Km, and
[S]0.5 were defined by fitting initial velocity data to
equations describing hyperbolic or cooperative saturation,
respectively. Hill coefficients (nH) were calculated
from Hill plots by linear regression.
|
|
To reveal the regulatory behavior of the enzyme, kinetic assays were
performed in the presence of allosteric effectors (Fig. 3A,
Table I). Tryptophan at 5 µM concentration has a strong
effect on the catalytic rate. Cooperativity is lost
(nH = 0.95), leading to a Michaelis-Menten-type
kinetic with a Km of 0.1 mM and the
maximal turnover number is increased to 92 s
1. In
contrast, tyrosine acts as inhibitor of chorismate mutase activity. 50 µM of this amino acid resulted in a [S]0.5
value of 6.4 mM with a turnover rate of 82.5 s
1. The Hill coefficient of 1.69 indicates the retained
cooperativity. The influence of tyrosine was further examined by
kinetic assays in the presence of different amounts of this effector.
Evaluation of these data according to Dixon (33) leads to a set of
linear curves, one for each chorismate concentration (Fig.
3B). The point of intersection reveals an inhibitory
constant Ki of 2.8 µM and further
indicates the type of mixed inhibition. In summary, chorismate mutase
of A. nidulans is tightly regulated in its catalytic
activity by tryptophan and tyrosine, with tryptophan as positive
effector having a stronger influence on enzymatic behavior. This is
indicated by the fact that alteration of enzyme kinetics is achieved at
10-fold lower concentration (5 µM) compared with the
inhibitory concentration of tyrosine (50 µM). The
allosteric effectors also show an influence on enzymatic activity with
respect to solvent pH (Fig. 3C). Tyrosine shifts the
catalytic maximum to a value of 5.4, whereas in the presence of
tryptophan maximal catalytic activity is achieved at pH 7.1. In
addition, tryptophan broadens the pH range of detectable catalytic activity.
The Chorismate Mutase of A. nidulans Is a Dimer--
In order to
elucidate the quaternary structure of the aroC gene product,
different approaches were carried out. By analytical ultracentrifugation a mean sedimentation constant S of 4.35 ± 0.2 was determined (data not shown). Using a calculated molecular mass of
30.0 kDa for one single chorismate mutase polypeptide, this S value
indicates the existence of a homodimeric structure. Gel filtration
analysis supports this result (Fig. 3D). The purified protein eluted from a calibrated Superdex 200 column at a defined elution volume corresponding to a Kd value of 0.67. This value matches the estimated Kd for a protein of
62.2 kDa, therefore the chorismate mutase had passed the column as a
dimer. Additionally, gradient polyacrylamide gel electrophoresis under
nondenaturing conditions indicated an apparent molecular mass of the
native enzyme of approximately 65 kDa (data not shown).
To analyze the structure of AROC, electron microscopic images of the
purified enzyme were taken at a magnification of 1:3.1 × 105 (Fig. 4A). The
images show the presence of a globular protein, approximately 13 × 7 nm in size. Different projections of the protein show a cleft
between two subunits, indicating a structure where two identical
subunits are connected by a dimeric interface.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 4.
The A. nidulans chorismate
mutase shares structural similarities with its yeast homologue and is
bound with high affinity by a polyclonal antibody against the yeast
enzyme. A, electron microscopy images show a globular
tertiary structure of chorismate mutase built up by two spherical
subunits. Pictures of the purified protein were taken at 3.1 × 105-fold magnification. Arrows point out two
molecules for which schematic models are shown on the right
side. Scale bar equals 32 nm. B, homology
modeling of A. nidulans chorismate mutase based on crystal
structures of the yeast enzyme. The primary sequence of the
aroC gene product was modeled on known three-dimensional
structures of yeast chorismate mutase monomers by SWISS-MODEL. In the
superimposition the tertiary structure of the yeast protein is
represented as gray ribbons, structures of AROC are
indicated as a black line. C indicates the C
terminus of the protein, N its N terminus. Important helices
(H) are indicated as well as loop220s connecting helix 11 and 12. The alignment shows a section of both enzymes compromising the
region of loop220s with identical residues in bold. C, a polyclonal rabbit antibody
raised against yeast chorismate mutase binds the AROC enzyme with high
affinity. The immunoblot shows 15 µg of crude extracts of yeast
strain RH2192 (aro7::LEU2) harboring different
2-µm expression plasmids. Lane 3 contains crude extract
from yeast strain RH2191 carrying one chromosomal copy of the
ARO7 gene. Proteins cross-reacting with polyclonal antiserum
raised against purified yeast chorismate mutase were detected using
enhanced chemiluminescence.
|
|
Antibodies against the Yeast Chorismate Mutase Recognize the A. nidulans Enzyme--
Given the globular, homodimeric structure of the
chorismate mutase from A. nidulans and its similarity in the
deduced amino acid sequence to the yeast enzyme, we performed molecular
modeling studies based on the homology to known crystal structures. A
three-dimensional structure of the A. nidulans enzyme was
deduced on the basis of the crystal structures of the yeast chorismate
mutases and the secondary structure elements of this newly created
structure were calculated. The proposed three-dimensional structure of
the enzyme from A. nidulans shows an all-helical structure
(Fig. 4B) consisting of 12 helices which resembles that of
the yeast protein. Superposition of both structures points out the
similarity between them which is highest for the helical elements.
Differences between the structures exist in the loops that connect
these helices, especially for the loop preceding helix 12 (loop220s).
The modeling studies suggest that similar epitopes exist on the
A. nidulans chorismate mutase in comparison to the yeast
enzyme. To test this hypothesis, we performed immunoblotting with a
polyclonal rabbit antibody raised against purified yeast chorismate
mutase. Western blots of cell extracts of yeast strain RH2192 harboring the coding cDNA for aroC or the ARO7 gene of
S. cerevisiae, respectively, on a 2-µm overexpression
plasmid revealed a high affinity of this antibody to the A. nidulans enzyme (Fig. 4C). Therefore, we conclude that
similar epitopes exist on both chorismate mutases and that the
structure of the A. nidulans enzyme resembles that of the yeast protein.
A Crucial Region for Allosteric Regulation of the Yeast Enzyme Is
Not Conserved in the A. nidulans Chorismate Mutase--
Given the
strong homology of the aroC gene product to yeast chorismate
mutase, we were interested in whether the mechanism of allosteric
transition is conserved in these related proteins. For the Aro7p of
S. cerevisiae, it has been shown that a single threonine
residue in loop220s (Thr226) is important for proper signal
transduction from the effector binding sites to the catalytic centers
of the homodimer (14). Exchange of that amino acid residue to
isoleucine (ARO7T226I) leads to a constitutively
activated enzyme that is locked in the R state. Upon
alignment of the primary structures of AROC and Aro7p, an aspartate
residue (Asp233) corresponds to that position in the
A. nidulans enzyme (Fig. 1B). By site-directed
mutagenesis, this residue was changed to threonine and isoleucine,
respectively, in the aroC gene product. Both alleles
(aroCD233T, aroCD233I)
were able to complement the yeast aro7
deletion
indicating that they are expressed properly in the recipient strain.
After overexpression in the yeast aro7
mutant strain
RH2192, desalted crude extracts were prepared and specific chorismate
mutase activities were determined in the absence or presence of
effectors, respectively. In addition, the corresponding ARO7
alleles, ARO7wt,
ARO7T226I, and ARO7T226D,
were expressed from the same plasmid in the aro7
strain
and the specific activities were determined in desalted crude extracts under identical conditions (Table
II).
View this table:
[in this window]
[in a new window]
|
Table II
Specific enzyme activities of mutant chorismate mutases
Catalytic activities were determined in desalted crude extracts of
yeast strain RH2192 expressing different chorismate mutase-encoding
alleles on a 2-µm overexpression plasmid driven by the
MET25 promoter. The values measured for each enzyme were
standardized for plasmid copy number by Southern analyses.
|
|
Generally, the A. nidulans chorismate mutase enzymes showed
higher specific activities in these assays than their yeast homologues. For the AROC wild-type enzyme a specific activity of 32.5 units/mg of
total protein was measured, which is repressed 3.9-fold to 8.4 units
mg
1 in the presence of 100 µM tyrosine,
whereas tryptophan at 500 µM concentration leads to a
2.7-fold increase in specific activity to a value of 88.5 units
mg
1. In contrast, yeast chorismate mutase activity
expressed from the ARO7T226D allele was measured
to be 3.7 units mg
1. In its inhibited form the enzyme is
slightly repressed in its activity (3.3 units mg
1). In
the presence of tryptophan, activity is increased 3-fold to 11.1 units
mg
1. The proteins with a substitution to isoleucine
clearly differ in their enzymatic properties. The unliganded
aroCD233I gene product shows a specific activity
of 30.3 units mg
1, which is repressed 2.3-fold when
liganded by tyrosine (13.4 units mg
1) and increased
2.1-fold to 63.0 units mg
1 by its activator tryptophan.
The yeast counterpart Aro7T226Ip has a specific activity of
20.6 units mg
1 and shows almost no regulatory response to
both effectors which is characteristic for this constitutively
activated enzyme. Substitution of residue 233 in the A. nidulans enzyme to threonine leads to a chorismate mutase with a
reduced regulatory range. The uneffected enzymatic activity of 41.3 units mg
1 is decreased 1.9-fold to 22.0 units
mg
1 by tyrosine and increased 1.6-fold to 64.3 units
mg
1 by tryptophan. The corresponding wt-Aro7p enzyme
shows a specific activity of 4.8 units mg
1 in its
unliganded state. This value is decreased 4-fold to 1.2 units
mg
1 in the presence of tyrosine, whereas tryptophan leads
to a 8.4-fold increase of specific activity to 40.2 units/mg of protein.
In summary, both AROC mutant proteins exhibit a reduced range of
regulatory properties in comparison to the wild-type enzyme. In the
wild-type enzyme, carrying the charged amino acid aspartate at position
233, modulation of chorismate mutase activity by the heterotropic
effectors tyrosine and tryptophan, respectively, is given by a factor
of 11. In the protein derived from the aroCD233I
mutant allele, the substitution to an apolar amino acid residue leads
to reduced modulation and enzymatic activity is within a range of 5. The AROCD233T protein shows almost no response to the
effectors with a narrow window of regulation by a factor of 3. The
exchange of the aspartate residue to the polar amino acid threonine
therefore seems to disturb the intramolecular signal transduction
pathway for the allosteric switch.
Taken together, the data clearly show that the chorismate mutase
enzymes of the bakers' yeast and the filamentous fungus A. nidulans share regulatory and structural properties. Despite these similarities the intramolecular signal transduction pathway for allosteric transition as proposed for the yeast enzyme seems to be not
conserved in the AROC protein.
 |
DISCUSSION |
The metabolic pathway of aromatic amino acid biosynthesis is a
conserved reaction cascade converting two compounds of primary metabolism to phenylalanine, tyrosine, and tryptophan. The flux of
compounds through this pathway has to be strictly regulated as
synthesis of aromatic amino acids is an energy-consuming process. One
mode of regulation lies in controlling the activity of branch point
enzymes within a pathway, either by altering their catalytic properties
or via altered enzyme levels within a cell. In the aromatic amino acid
biosynthetic pathway, the chorismate mutase enzyme is one major point
of attack in regulating the flux of chorismic acid into the
tyrosine/phenylalanine-specific branch.
We have demonstrated that the protein specified by the aroC
gene of A. nidulans is the chorismate mutase enzyme of this
filamentous fungus. According to its high sequence similarity to the
monofunctional chorismate mutase of S. cerevisiae the
A. nidulans enzyme has to be classified as a member of the
AroQ class of chorismate mutases. The kinetic properties of this enzyme
demonstrate that the aroC gene product is tightly regulated
in its activity. The substrate, chorismate, serves as homotropic,
positive effector as deduced from positive cooperativity in substrate
saturation assays. The determined Hill coefficient of 1.56 clearly
indicates that the enzyme contains at least two substrate-binding
sites. In addition, two aromatic amino acids show heterotropic effects
on enzymatic activity. Tyrosine, one end product of the chorismate
mutase-specific branch, influences catalytic efficiency negatively,
whereas tryptophan, the end product of the opposite branch, strongly
increases catalytic turnover. Therefore this chorismate mutase enzyme
fits well in the model of allosterism as established by Monod and
co-workers (49). In this simple model a given enzyme exists in two (or more) structural states, tense (T-) or relaxed
(R-), with different catalytic activities. The equilibrium
between these states is changed upon substrate binding to the active
site or by binding of inhibitory or activating ligands at distinct
allosteric sites. Further reference to allosterism is given by the
homodimeric structure of the A. nidulans chorismate mutase
since allosteric enzymes are often multimeric proteins.
pH dependence of catalytic activity of the chorismate mutase from
A. nidulans shows three distinct optima. For the unliganded enzyme the pH optimum of 5.9 fits quite well the intracellular pH in
filamentous fungi, which is in a range of 5.7 to 6.5 (50). The negative
effector tyrosine shifts this optimum only slightly to a value of 5.4, whereas tryptophan alters the range of catalytic activity dramatically:
maximum turnover is achieved at the neutral pH of 7.1 and catalytic
activity is present over a pH range between 4 and 12. This
pH-dependent catalytic behavior is contrary to that known
from bacterial chorismate mutases where highest catalytic activities
are achieved at alkaline pH (51, 52). On the other hand the catalytic
activities of the A. nidulans enzyme at different pH values
resemble that of yeast chorismate mutase. For the A. nidulans chorismate mutase, similar absolute catalytic activities were determined as described for the yeast enzyme (10). Without any
effector present, enzymatic activity was measured over 4.5 pH units and
tyrosine restricted catalytic activity to a range of 3 pH units (Fig.
3C). One difference concerning pH dependence is the range of
detectable catalytic activity in the presence of tryptophan. The
heterotropic positive effector broadens the pH range of activity to 8 pH units compared with a value of 6 units as reported for the S. cerevisiae enzyme. In the yeast protein the active site residue
Glu246 has been identified to be important in restricting
enzyme activity to acidic conditions (10). Upon alignment, this
particular residue is conserved within the primary structure of the
A. nidulans enzyme (Glu253).
In yeast chorismate mutase, different domains within the dimeric
structure have been identified (53). Upon effector binding, the two
subunits rotate relative to each other and the allosteric signal is
transmitted toward the polypeptide to the catalytic domain. The dimeric
structure and all specific amino acids of the yeast enzyme which are
important for binding of effectors (Arg75,
Arg76, Asn139, Ser142, and
Thr145) and allosteric signal transduction
(Glu23, Asp24, Phe28, and
Tyr234), as well as active site residues
(Arg16, Arg157, Lys168,
Glu198, and Thr242) are conserved in the
chorismate mutase of A. nidulans (Fig. 1B).
Additionally, in silico studies showed that AROC can be
modeled quite closely onto the tertiary structure of the yeast protein. Therefore, it was surprising that one particular residue,
Thr226, of the yeast enzyme is not conserved in its
A. nidulans counterpart, as this residue had been
characterized as the molecular switch in transmitting the signal for
T to R state transition (9). By site-directed
mutagenesis we created two mutant AROC enzymes. None of these enzymes
turned out to be locked in either allosteric state, but both proteins
showed decreased regulatory properties upon effector binding. We
conclude that this narrow window of regulatory modulation represents
intermediate states between tense and relaxed state. The role of
loop220s in transmitting the intramolecular signal from the effector
binding sites to the catalytic domains is obviously different in the
chorismate mutases of S. cerevisiae and A. nidulans. Whereas in the yeast protein substitution of one
particular residue in loop220s locks the whole enzyme in its activated
state, we did not find such a behavior in the AROC mutant enzymes.
Taking into account that the A. nidulans enzyme resembles its yeast homologue with respect to catalytic and regulatory behavior as well as structural properties this difference is surprising. It
implicates that the structure of this loop preceding helix 12, which is
part of the catalytic domain, is more flexible in the A. nidulans enzyme than in the yeast chorismate mutase. Additionally, we suggest that alternative pathways within the molecule could exist
for signal transduction to the active site in contrast to one exclusive
via loop220s.
Allosterism is one possible way in regulating enzymatic activity. In
living systems additional mechanisms of flux control through a
metabolic pathway exist which affect the rate of expression of a given
enzyme. For the aroC gene product data indicate that its
expression is not regulated transcriptionally via the cross-pathway control network (54). Amino acid starvation conditions showed no
influence on aroC transcript levels which is consistent with data obtained for S. cerevisiae (55). Sequence analysis for upstream regulatory sequences indicated a putative STUA-binding site
560 nucleotides upstream of the translational start codon of
aroC. This sequence element matches the described consensus for STUA response elements (42). As a filamentous fungus A. nidulans has developed additional regulatory networks that
constitute differentiation processes. Preliminary transcript level
analyses indicate that aroC expression is down-regulated
drastically after the developmental program of asexual conidiation is
initiated (not shown). Future research will have to identify
trans factors as well as cis elements responsible
for this type of regulation and elucidate whether this is specific for
chorismate mutase expression or, in contrast, is a general effect after
the developmental program has been established.
 |
ACKNOWLEDGEMENTS |
We thank Gaby Heinrich for support in the
initial phase, Dr. Hans-Ulrich Mösch for critical reading of the
manuscript, and all other members of the laboratory for helpful
discussions. We also thank Dr. Christian Urbanke, Hannover, for
determining the native molecular weight on an ultracentrifuge.
 |
FOOTNOTES |
*
This work was supported by grants from the Deutsche
Forschungsgemeinschaft, Fonds der Chemischen Industrie,
Volkswagen-Stiftung, and the Niedersächsischen Vorab der
Volkswagen-Stiftung, Forschungsstelle für nachwachsende
Rohstoffe.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Dedicated to Prof. Dr. William N. Lipscomb on the occasion of his 80th birthday.
To whom correspondence should be addressed. Tel.:
49-0-551-39-3770; Fax: 49-0-551-39-3820; E-mail: gbraus@gwdg.de.
 |
ABBREVIATIONS |
The abbreviations used are:
kb, kilobase(s);
bp, base pair(s).
 |
REFERENCES |
| 1.
|
Weiss, U.,
and Edwards, J. M.
(1980)
The Biosynthesis of Aromatic Amino Acids
, Wiley, New York
|
| 2.
|
Braus, G. H.
(1991)
Microbiol. Rev.
55,
349-370[Abstract/Free Full Text]
|
| 3.
|
Andrews, P. R.,
Smith, G. D.,
and Young, I. G.
(1973)
Biochemistry
12,
3492-3498[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Romero, R. M.,
Roberts, M. F.,
and Phillipson, J. D.
(1995)
Phytochemistry
40,
1015-1025[CrossRef]
|
| 5.
|
Chook, Y. M.,
Ke, H.,
and Lipscomb, W. N.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
8600-8603[Abstract/Free Full Text]
|
| 6.
|
Chook, Y. M.,
Gray, J. V.,
Ke, H.,
and Lipscomb, W. N.
(1994)
J. Mol. Biol.
240,
476-500[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Gu, W.,
Williams, D. S.,
Aldrich, H. C.,
Xie, G.,
Gabriel, D. W.,
and Jensen, R. A.
(1997)
Microb. Comp. Genomics
2,
141-158
[Medline]
[Order article via Infotrieve] |
| 8.
|
MacBeath, G.,
Kast, P.,
and Hilvert, D.
(1998)
Biochemistry
37,
10062-10073[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Schmidheini, T.,
Sperisen, P.,
Paravicini, G.,
Hütter, R.,
and Braus, G.
(1989)
J. Bacteriol.
171,
1245-1253[Abstract/Free Full Text]
|
| 10.
|
Schnappauf, G.,
Sträter, N.,
Lipscomb, W. N.,
and Braus, G. H.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
8491-8496[Abstract/Free Full Text]
|
| 11.
|
Schnappauf, G.,
Krappmann, S.,
and Braus, G. H.
(1998)
J. Biol. Chem.
273,
17012-17017[Abstract/Free Full Text]
|
| 12.
|
Sträter, N.,
Schnappauf, G.,
Braus, G. H.,
and Lipscomb, W. N.
(1997)
Stucture
5,
1437-1452[Medline]
[Order article via Infotrieve]
|
| 13.
|
Ma, J.,
Zheng, X.,
Schnappauf, G.,
Braus, G.,
Karplus, M.,
and Lipscomb, W. N.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14640-14645[Abstract/Free Full Text]
|
| 14.
|
Schmidheini, T.,
Mösch, H.-U.,
Evans, J. N. S.,
and Braus, G.
(1990)
Biochemistry
29,
3660-3668[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Martinelli, S. D., and Kinghorn, J. R.
(eds)
(1994)
Aspergillus, 50 Years on: Progress in Industrial Microbiology
, Elsevier Science B. V., Amsterdam
|
| 16.
|
Adams, T. H.,
Wieser, J. K.,
and Yu, J.-H.
(1998)
Microbiol. Mol. Biol. Rev.
62,
35-54[Abstract/Free Full Text]
|
| 17.
|
Dimroth, P.
(1986)
Methods Enzymol.
125,
530-540[Medline]
[Order article via Infotrieve]
|
| 18.
|
Liu, H.,
Krizek, J.,
and Bretscher, A.
(1992)
Genetics
132,
665-673[Abstract]
|
| 19.
|
Elble, R.
(1992)
BioTechniques
13,
18-20[Medline]
[Order article via Infotrieve]
|
| 20.
|
Punt, P. J.,
and van den Hondel, C. A. M. J. J.
(1992)
Methods Enzymol.
216,
447-457[Medline]
[Order article via Infotrieve]
|
| 21.
|
Mumberg, D.,
Müller, R.,
and Funk, M.
(1994)
Nucleic Acids Res.
22,
5767-5768[Free Full Text]
|
| 22.
|
Heinemeyer, W.,
Kleinschmidt, J. A.,
Saidowsky, J.,
Escher, C.,
and Wolf, D. H.
(1991)
EMBO J.
10,
555-562[Medline]
[Order article via Infotrieve]
|
| 23.
|
Roberts, C. F.
(1969)
Aspergillus Newsletter
10,
19-21
|
| 24.
|
Miozzari, G.,
Niederberger, P.,
and Hütter, R.
(1978)
J. Bacteriol.
134,
48-59[Abstract/Free Full Text]
|
| 25.
|
Käfer, E.
(1977)
Adv. Gen.
19,
33-131
|
| 26.
|
Giebel, L. B.,
and Spritz, R. A.
(1990)
Nucleic Acids Res.
18,
4947[Free Full Text]
|
| 27.
|
Sanger, F.,
Nicklen, S.,
and Coulson, A. R.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
5463-5467[Abstract/Free Full Text]
|
| 28.
|
Alwine, J. C.,
Kemp, D. J.,
and Stark, G. R.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
5350-5354[Abstract/Free Full Text]
|
| 29.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Fletcher, R.,
and Powell, M. J. D.
(1963)
Computer J.
6,
163-168
|
| 32.
|
Newell, J. O.,
and Schachmann, H. K.
(1990)
Biophys. Chem.
37,
183-196[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Dixon, M.
(1953)
J. Biochem.
55,
170-171
|
| 34.
|
Andersson, L. O.,
Borg, H.,
and Mikaelsson, M.
(1972)
FEBS Lett.
20,
199-202[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Valentine, R. C.,
Shapiro, P. M.,
and Stadtman, E. R.
(1968)
Biochemistry
7,
2143-2152[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Tesfaigzi, J.,
Smith-Harrison, W.,
and Carlson, D. M.
(1994)
BioTechniques
17,
268-269[Medline]
[Order article via Infotrieve]
|
| 37.
|
Lipman, D. J.,
and Pearson, W. R.
(1985)
Science
227,
1435-41[Abstract/Free Full Text]
|
| 38.
|
Peitsch, M. C.
(1996)
Biochem. Soc. Trans.
24,
274-279[Medline]
[Order article via Infotrieve]
|
| 39.
|
Peitsch, M. C.
(1995)
Bio/Technology
13,
658-660[CrossRef]
|
| 40.
|
Guex, N.,
and Peitsch, M. C.
(1997)
Electrophoresis
18,
2714-2723[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Koradi, R.,
Billeter, M.,
and Wüthrich, K.
(1996)
J. Mol. Graph.
14,
51-55[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
May, G. S.,
Tsang, M. L.-S.,
Smith, H.,
Fidel, S.,
and Morris, N. R.
(1987)
Gene (Amst.)
55,
231-243[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Dutton, J. R.,
Johns, S.,
and Miller, B. L.
(1997)
EMBO J.
16,
5710-5721[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Hinnebusch, A. G.
(1988)
Microbiol. Rev.
52,
248-273[Free Full Text]
|
| 45.
|
Zaudy, G.
(1969)
Aspergillus Newsletter
10,
22
|
| 46.
|
Hilton, J. L.,
Kearney, P. C.,
and Ames, B. N.
(1965)
Arch. Biochem. Biophys.
112,
544-547[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Punt, P. J.,
Dingemanse, M. A.,
Jacobs-Meijsing, B. J. M.,
Pouwels, P. H.,
and van den Hondel, C. A. M. J. J.
(1988)
Gene (Amst.)
69,
49-57[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Yelton, M. M.,
Hamer, J. E.,
deSouza, E. R.,
Mullaney, E. J.,
and Timberlake, W. E.
(1983)
Proc. Natl. Acad. Sci. U. S. A.
80,
7576-7580[Abstract/Free Full Text]
|
| 49.
|
Monod, J.,
Changeux, J. P.,
and Jacob, F.
(1963)
J. Mol. Biol.
6,
306-329[Medline]
[Order article via Infotrieve]
|
| 50.
|
Caddick, M. X.,
Brownlee, A. G.,
and Arst, H. N., Jr.
(1986)
Mol. Gen. Genet.
203,
346-353[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Schmit, J. C.,
and Zalkin, H.
(1969)
Biochemistry
8,
174-181[Medline]
[Order article via Infotrieve]
|
| 52.
|
Dopheide, T. A. A.,
Crewther, P.,
and Davidson, B. E.
(1972)
J. Biol. Chem.
247,
4447-4452[Abstract/Free Full Text]
|
| 53.
|
Sträter, N.,
Håkansson, K.,
Schnappauf, G.,
Braus, G.,
and Lipscomb, W. N.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
3330-3334[Abstract/Free Full Text]
|
| 54.
|
Piotrowska, M.
(1980)
J. Gen. Microbiol.
116,
335-339
|
| 55.
|
Schmidheini, T.,
Mösch, H.-U.,
Graf, R.,
and Braus, G. H.
(1990)
Mol. Gen. Genet.
224,
57-64[Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles: